<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCN</journal-id>
<journal-id journal-id-type="hwp">spjcn</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-title>Journal of Child Neurology</journal-title>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883073811424797</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883073811424797</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Communication</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Further Magnetic Resonance Imaging (MRI) Brain Delineation of 49,XXXXY Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Tabarki</surname>
<given-names>Brahim</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0883073811424797">1</xref>
<xref ref-type="corresp" rid="corresp1-0883073811424797"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shafi</surname>
<given-names>Shatha Al</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0883073811424797">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adwani</surname>
<given-names>Nawal Al</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073811424797">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shahwan</surname>
<given-names>Saad Al</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0883073811424797">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0883073811424797">
<label>1</label>Division of Pediatric Neurology, Department of Pediatrics, Riyadh Military Hospital, Riyadh, Saudi Arabia</aff>
<aff id="aff2-0883073811424797">
<label>2</label>Department of Radiology, Riyadh Military Hospital, Riyadh, Saudi Arabia</aff>
<author-notes>
<corresp id="corresp1-0883073811424797">Brahim Tabarki, MD, Department of Pediatrics, Riyadh Military Hospital, PO Box 7897, Riyadh 11159, Saudi Arabia Email: <email>btabarki@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>5</issue>
<fpage>650</fpage>
<lpage>653</lpage>
<history>
<date date-type="received">
<day>18</day>
<month>6</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>9</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>A rare sex chromosome aneuploidy syndrome, 49,XXXXY syndrome is characterized by mental retardation with severe learning difficulties, craniofacial and skeletal abnormalities, hypogonadism, and congenital heart disease. The authors describe a 30-month-old boy with 49,XXXXY syndrome, global developmental delay and white matter changes in the brain magnetic resonance imaging. They reviewed the literature to delineate a specific magnetic resonance imaging pattern of 49,XXXXY syndrome.</p>
</abstract>
<kwd-group>
<kwd>49</kwd>
<kwd>XXXXY syndrome</kwd>
<kwd>magnetic resonance imaging brain</kwd>
<kwd>white matter</kwd>
<kwd>aneuploidy</kwd>
<kwd>Klinefelter</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Pentasomy 49,XXXXY is a rare sex chromosome polysomy, often considered a severe variant of Klinefelter syndrome (47,XXY). The syndrome is clinically expressed as a combination of mental retardation; facial dysmorphism; and genital, cardiac, and skeletal malformations. The incidence of the condition is estimated to be 1 in 85 000 male births.<sup>
<xref ref-type="bibr" rid="bibr1-0883073811424797">1</xref>
</sup>
</p>
<p>Chromosomal disorders are associated with a wide range of abnormalities of the central nervous system.<sup>
<xref ref-type="bibr" rid="bibr2-0883073811424797">2</xref>,<xref ref-type="bibr" rid="bibr3-0883073811424797">3</xref>
</sup> Although 47,XXY was associated with a smaller brain volume on magnetic resonance imaging (MRI),<sup>
<xref ref-type="bibr" rid="bibr4-0883073811424797">4</xref>
</sup> the number of reports regarding MRI findings in 49,XXXXY is extremely limited.<sup>
<xref ref-type="bibr" rid="bibr2-0883073811424797">2</xref>,<xref ref-type="bibr" rid="bibr5-0883073811424797">5</xref>
<xref ref-type="bibr" rid="bibr6-0883073811424797"/>–<xref ref-type="bibr" rid="bibr7-0883073811424797">7</xref>
</sup>
</p>
<p>We describe brain MRI findings on a patient with 49,XXXXY and reviewed the literature to delineate a specific MRI pattern of 49,XXXXY syndrome.</p>
<sec id="section1-0883073811424797">
<title>Case Report</title>
<p>This male patient was born at term to consanguineous parents following a normal pregnancy and delivery, with a birth weight of 2.55 kg and head circumference of 32.5 cm. (All these parameters are below the 3rd percentile.) He was referred for a neurologic evaluation at the age of 30 months. He is known to have congenital heart disease (atrial septal defect ostium secundum type), right squint, and small genitalia. Neurological examination showed microcephaly (head circumference is 44 cm; &lt; 2 standard deviations) and dysmorphic features. He was following, fixating, and reacting. There was mild hypotonia with normal power and deep tendon reflexes. Assessment by the <italic>Denver Development Screening Test</italic>
<sup>
<xref ref-type="bibr" rid="bibr8-0883073811424797">8</xref>
</sup> showed global developmental delay: gross motor, 11 months; language, 11 to 12 months; fine motor, 9 to 10 months; and personal–social, 10 to 11 months.</p>
<p>Brain MRI at 30 months showed moderate ventriculomegaly with dilatation of the occipital horn of the lateral ventricles, and a thin body of the corpus callosum. T2-weighted images (<xref ref-type="fig" rid="fig1-0883073811424797">Figure 1</xref>) demonstrate symmetrical bilateral increase in signal intensity involving the parieto-occipital lobes and, to a lesser extent, frontal lobe sparing the subcortical U-fibers. Also, there is increased signal intensity involving both spinothalamic tracts, which show restricted diffusion in diffusion-weighted images (<xref ref-type="fig" rid="fig2-0883073811424797">Figures 2a</xref> and <xref ref-type="fig" rid="fig2-0883073811424797">b</xref>). Brain MRI favored dysmyelinating white matter changes. Extensive metabolic work-up and virologic studies for congenital infections were negative. Karyotype analysis revealed 49,XXXXY in 26 out of 26 cells counted.</p>
<fig id="fig1-0883073811424797" position="float">
<label>Figure 1.</label>
<caption>
<p>Brain magnetic resonance imaging (MRI). Axial T2-weighted image of the brain demonstrates symmetrical bilateral increase in signal intensity involving the parieto-occipital lobes and, to a lesser extent, frontal lobe sparing the subcortical U-fibers.</p>
</caption>
<graphic alternate-form-of="fig1-0883073811424797" xlink:href="10.1177_0883073811424797-fig1.tif"/>
</fig>
<fig id="fig2-0883073811424797" position="float">
<label>Figure 2.</label>
<caption>
<p>Brain magnetic resonance imaging (MRI). (a) Axial T2-weighted image of the brain demonstrates increased signal intensity involving both spinothalamic tracts, which (b) show restricted diffusion in diffusion-weighted images.</p>
</caption>
<graphic alternate-form-of="fig2-0883073811424797" xlink:href="10.1177_0883073811424797-fig2.tif"/>
</fig>
</sec>
<sec id="section2-0883073811424797">
<title>Discussion</title>
<p>Variation in the number of sex chromosomes (sex chromosome aneuploidies) is a relatively common genetic condition, affecting as many as 1 in 400 individuals. Supernumerary X chromosomes can affect development of the cardiac, endocrine, reproductive, skeletal, and central nervous systems.<sup>
<xref ref-type="bibr" rid="bibr3-0883073811424797">3</xref>
</sup> Klinefelter syndrome (also known as 47,XXY) is the most common sex-chromosome aneuploidy. 47,XXY males have characteristic, but highly variable, cognitive and behavioral features. The most frequently documented cognitive impairments, occurring in 80% of those with XXY, are language-based learning disorders. Brain MRI studies on patients with Klinefelter syndrome have provided evidence that sex-chromosome polysomy exerts specific effects on brain development. MRI studies showed that total cerebral volume and all lobar volumes except parietal white matter were significantly smaller in the XXY group, whereas lateral-ventricle volume was larger. The cortex was significantly thinner in the XXY group in left inferior frontal, temporal, and superior motor regions.<sup>
<xref ref-type="bibr" rid="bibr4-0883073811424797">4</xref>
</sup>
</p>
<p>The number of reports on brain imaging in patients with severe Klinefelter variants is, however, extremely limited.<sup>
<xref ref-type="bibr" rid="bibr2-0883073811424797">2</xref>,<xref ref-type="bibr" rid="bibr5-0883073811424797">5</xref>
<xref ref-type="bibr" rid="bibr6-0883073811424797"/>–<xref ref-type="bibr" rid="bibr7-0883073811424797">7</xref>
</sup> A 49,XXXXY karyotype is thought to arise from maternal nondisjunction, which occurs during both meiosis I and meiosis II. This produces a secondary oocyte with 4 X chromosomes, which when fertilized by a Y chromosome bearing sperm, results in an embryo with 49,XXXXY syndrome.</p>
<p>Only 6 reports on brain MRI in 49,XXXXY have been published.<sup>
<xref ref-type="bibr" rid="bibr2-0883073811424797">2</xref>,<xref ref-type="bibr" rid="bibr5-0883073811424797">5</xref>
<xref ref-type="bibr" rid="bibr6-0883073811424797"/>–<xref ref-type="bibr" rid="bibr7-0883073811424797">7</xref>
</sup> The main findings from these reports and our case are summarized in <xref ref-type="table" rid="table1-0883073811424797">Table 1</xref>. White matter anomalies are present in 5 patients and have the same pattern: these changes are mainly periventricular and deep periventricular sparing the subcortical U-fibers. The severity of these white matter anomalies is variable, ranging from extensive confluent white matter disease to punctate foci of signal abnormality. Brain stem lesions observed bilaterally in the pyramidal tracts seen in our patient has never been reported. Corpus callosum, internal capsule, and cerebellum have normal myelination. In some patients other associated anomalies are observed including thin corpus callosum, global cerebral atrophy, and enlargement of the lateral ventricules.</p>
<table-wrap id="table1-0883073811424797" position="float">
<label>Table 1.</label>
<caption>
<p>Clinical and Neuroradiological Findings for Patients with 49,XXXXY Investigated by Magnetic Resonance Imaging (MRI)</p>
</caption>
<graphic alternate-form-of="table1-0883073811424797" xlink:href="10.1177_0883073811424797-table1.tif"/>
<table>
<thead>
<tr>
<th>Patient</th>
<th>Age</th>
<th>Neurologic status</th>
<th>Brain MRI</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patient 1<sup>2</sup>
</td>
<td>1 y</td>
<td>Mild psychomotor delay</td>
<td>Extensive white matter hyperintensities of the subcortical area</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Hypoplasia of the corpus callosum</td>
</tr>
<tr>
<td>Patient 2<sup>5</sup>
</td>
<td>14 mo</td>
<td>Hypotonia Developmental delay</td>
<td>Periventricular and deep white matter changes of the parietal and frontal lobes bilaterally sparing the subcortical U-fibers</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Moderate ventriculomegaly</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Thin body of the corpus callosum</td>
</tr>
<tr>
<td>Patient 3<sup>5</sup>
</td>
<td>7 y</td>
<td>Mental retardation</td>
<td>Periventricular and subcortical white matter changes</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Thinning of the corpus callosum</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Enlargement of the lateral ventricules</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Some cerebral volume loss</td>
</tr>
<tr>
<td>Patient 4<sup>5</sup>
</td>
<td>39 y</td>
<td>Seizures</td>
<td>Periventricular, deep, and subcortical white matter changes</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>Developmental delay</td>
<td>Thinning of the corpus callosum</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Volume loss and atrophy</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Increase in ventricular size</td>
</tr>
<tr>
<td>Patient 5<sup>6</sup>
</td>
<td>12 y</td>
<td>Microcephaly</td>
<td>Cortical atrophy</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>Developmental delay</td>
<td>Enlarged lateral ventricules</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>Seizures</td>
<td>
</td>
</tr>
<tr>
<td>Patient 6<sup>7</sup>
</td>
<td>3 y</td>
<td>Developmental delay</td>
<td>Hypoplasia of the corpus callosum</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Enlarged ventricles</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>General decrease of the volume of the cerebral cortex</td>
</tr>
<tr>
<td>Our patient 7</td>
<td>2½ y</td>
<td>Developmental delay</td>
<td>White matter changes of the parieto-occipital lobes with U-fibers sparing</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Thin corpus callosum</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Enlarged ventricules</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>Involvement of spinothalamic tracts</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The most striking findings in these patients are the white matter changes. Various chromosomal disorders have been associated with delayed myelination or a decreased volume of white matter. Alterations of white matter in chromosomal disorders have mainly been reported in patients with 18q- syndrome.<sup>
<xref ref-type="bibr" rid="bibr9-0883073811424797">9</xref>
</sup> Findings are diffuse bilateral symmetric T2 hyperintensity images most prominent in periventricular regions and most pronounced in posterior areas, with normal myelination in the brainstem, cerebellum, and corpus callosum. Molecular studies have demonstrated a relation between these abnormalities and the haploinsufficiency of the gene encoding myelin basic protein. In 49,XXXXY syndrome, however, the exact mechanism of the white matter changes is unknown. Supernumerary X may have an effect on the regulation of myelination processes. Furthermore, androgen may play a role in this process, as recently shown by Samango-Sprouse et al that treatment of 49,XXXXY with androgen has a significant positive effect in the speech and language domain, gestural communication, and vocabulary development.<sup>
<xref ref-type="bibr" rid="bibr1-0883073811424797">1</xref>
</sup> In several meta-analyses, T2 hyperintensities were correlated with a loss of global cognitive functions.</p>
</sec>
<sec id="section3-0883073811424797">
<title>Conclusion</title>
<p>Cerebral white matter changes in children are generally considered suggestive of an underlying metabolic defect. Our findings and the review of the literature also strongly suggest that chromosomal abnormalities, and in particular 49,XXXXY syndrome, should also be considered.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-0883073811424797">
<p>The first draft of the manuscript was prepared by BT. Major revisions and final manuscript preparation were done equally by all authors.</p>
</fn>
<fn fn-type="conflict" id="fn2-0883073811424797">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-0883073811424797">
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="other" id="fn4-0883073811424797">
<p>This work was performed in agreement with the ethical rules of our institution, Riyadh Military Hospital.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0883073811424797">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samango-Sprouse</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Gropman</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Sadeghin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kingery</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lutz-Armstrong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rogol</surname>
<given-names>AD</given-names>
</name>
</person-group>. <article-title>Effects of short-course androgen therapy on the neurodevelopmental profile of infants and children with 49,XXXXY syndrome</article-title>. <source>Acta Paediatr</source>. <year>2011</year>;<volume>100</volume>:<fpage>861</fpage>-<lpage>865</lpage>.</citation>
</ref>
<ref id="bibr2-0883073811424797">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Cazorla</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sans</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Baquero</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>White matter alterations associated with chromosomal disorders</article-title>. <source>Dev Med Child Neurol</source>. <year>2004</year>;<volume>46</volume>:<fpage>148</fpage>-<lpage>153</lpage>.</citation>
</ref>
<ref id="bibr3-0883073811424797">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lenroot</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Giedd</surname>
<given-names>JN</given-names>
</name>
</person-group>. Effects of sex chromosome aneuploidies on brain development: evidence from neuroimaging studies. <source>Dev Disabil Res Rev</source>. <year>2009</year>;<volume>15</volume>:<fpage>318</fpage>-<lpage>327</lpage>.</citation>
</ref>
<ref id="bibr4-0883073811424797">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giedd</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Clasen</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>GL</given-names>
</name>
<etal/>
</person-group>. <article-title>XXY (Klinefelter syndrome): a pediatric quantitative brain magnetic resonance imaging case–control study</article-title>. <source>Pediatrics</source>. <year>2007</year>;<volume>119</volume>:<fpage>e232</fpage>-<lpage>e240</lpage>.</citation>
</ref>
<ref id="bibr5-0883073811424797">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffman</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Vossough</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ficicioglu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Visootsak</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Brain magnetic resonance imaging findings in 49,XXXXY syndrome</article-title>. <source>Pediatr Neurol</source>. <year>2008</year>;<volume>38</volume>:<fpage>450</fpage>-<lpage>453</lpage>.</citation>
</ref>
<ref id="bibr6-0883073811424797">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galasso</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Arpino</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fabbri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Curatolo</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Neurologic aspects of 49,XXXXY syndrome</article-title>. <source>J Child Neurol</source>. <year>2003</year>;<volume>18</volume>:<fpage>501</fpage>-<lpage>504</lpage>.</citation>
</ref>
<ref id="bibr7-0883073811424797">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haeusler</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Frisch</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Guchev</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hadziselimovic</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Neuhold</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vormittag</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Hypoplasia of the corpus callosum and growth hormone deficiency in the XXXXY syndrome</article-title>. <source>Am J Med Genet</source>. <year>1992</year>;<volume>44</volume>:<fpage>230</fpage>-<lpage>232</lpage>.</citation>
</ref>
<ref id="bibr8-0883073811424797">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frankenburg</surname>
<given-names>WK</given-names>
</name>
<name>
<surname>Dodds</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Archer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bresnick</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>The <italic>Denver II</italic>: a major revision and restandardization of the</article-title> <source>Denver Development Screening Test</source>. <source>Pediatrics</source>. <year>1992</year>;<volume>89</volume>:<fpage>91</fpage>-<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr9-0883073811424797">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loevner</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Grossman</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Overhauser</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kamholz</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>White matter changes associated with deletions of the long arm of chromosome 18 (18q- syndrome): a dysmyelinating disorder?</article-title> <source>Am J Neuroradiol</source>. <year>1996</year>;<volume>17</volume>:<fpage>1843</fpage>-<lpage>1848</lpage>.</citation>
</ref>
<ref id="bibr10-0883073811424797">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Debette</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Markus</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis</article-title>. <source>BMJ</source>. <year>2010</year>;<volume>34</volume>:<fpage>c3666</fpage>.</citation>
</ref>
<ref id="bibr11-0883073811424797">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oosterman</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Sergeant</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Weinstein</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Scherder</surname>
<given-names>EJ</given-names>
</name>
</person-group>. <article-title>Timed executive functions and white matter in aging with and without cardiovascular risk factors</article-title>. <source>Rev Neurosci</source>. <year>2004</year>;<volume>15</volume>:<fpage>439</fpage>-<lpage>462</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>